Beijing Compete Pharmaceutical Co., Ltd. Report issue

Government Phase 2 Phase 4
Founded: Beijing China

Organization Overview

First Clinical Trial
2017
NCT03230071
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing Compete Medical Technology Development Co. Ltd. | Beijing Compete Pharmaceutical Co., Ltd.